Atlas Trials

Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection

Clinical trial NCT02707900 · TERMINATED

Trial details

NCT number
NCT02707900
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2016-03-01
Primary completion
2018-07-11
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.